Document is current
Any future updates will be listed below
-
Authors
Bourgonje, Arno R.
Posner, Hannah
Carbonnel, Franck
Colombel, Jean-Frédéric
Kayal, Maia
-
Funding
Funding for this research was provided by:
Netherlands Organization for Scientific Research (452022317)
- License Information
-
More Information
Article History
Received: 4 November 2024
Accepted: 17 December 2024
First Online: 2 January 2025
Declarations
:
: The corresponding author confirms on behalf of all authors that there have been no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated. ARB reports receiving research grants from Janssen Pharmaceuticals and received speaker’s fees from AbbVie and Ferring Pharmaceuticals. JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals, Takeda, and Bristol Myers Squibb; receiving payment for lectures from AbbVie and Takeda; receiving consulting fees from AbbVie, Amgen, AnaptysBio, Allergan, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Celltrion, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Glaxo Smith Kline, Genentech (Roche), Janssen Pharmaceuticals, Kaleido Biosciences, Immunic, Invea, Iterative Scopes, Merck, Landos, Microba Life Science, Novartis, Nautilus, Otsuka Pharmaceutical, Pfizer, Protagonist Therapeutics, Prometheus, Sanofi, Seres, Takeda, Teva, TiGenix, and Vifor; and hold stock options in Intestinal Biotech Development. MK has served as a consultant or received advisory board fees from AbbVie, Pfizer, BMS, Janssen, and Fresenius Kabi. The remaining authors disclose no conflicts.
